Schott Pharma announced that it developed a new nest design for prefillable polymer syringes for increased pharmaceutical output. The new nest holds a total of 160 syringes without changing the size of the nest. That marks an increase of 60% compared to the standard nest that fits 100 syringes. According to a news release, this…
Schott Pharma commits $371 million to new U.S. manufacturing facility for GLP-1, mRNA therapies
Pharma packaging company Schott Pharma has unveiled plans to establish a new manufacturing facility in Wilson, North Carolina. Schott Pharma says the $371 million investment in the U.S. facility will create more than 400 jobs in the region and significantly expand the company’s presence in the U.S., an increasingly important strategic market for the German…
Two continents, two milestones: Schott Pharma’s American commitment and European stock market debut
Drug containment company Schott Pharma recently celebrated major milestones related to its longstanding U.S. presence and high-profile stock market debut in Germany. The company, a division of specialty glass manufacturer Schott AG based in Mainz, Germany, commemorated 60 years of operations in the U.S. in August. Its primary American facility located in Lebanon County, Pennsylvania…